| abstract |
The use of a physiologically innocuous ammonium compound and/or urea as an additive to an infant formula or a pap or for the preparation of a pharmaceutical composition for the prophylaxis of sudden infant death syndrome (SIDS) is claimed. Also claimed is an infant formula or a pap, which in addition to conventional ingredients contains a physiologically innocuous ammonium compound and/or urea. A method for the diagnosis of the risks for SIDS is claimed wherein the faeces of the infant are analyzed with respect to the presence of urea, urease activity and/or ammonium ions, the presence of urea, the absence or abnormally low urease activity and ammonium ion, respectively, indicating risks for SIDS. |